Similar humoral immune responses in peritoneal dialysis and haemodialysis patients after two doses of the SARS-CoV-2 vaccine BNT162b2

Perit Dial Int. 2022 Jan;42(1):100-101. doi: 10.1177/08968608211055631. Epub 2021 Nov 9.

Authors

Affiliations

¹ Center for Renal, Hypertensive and Metabolic Disorders (ZNHS) Hannover, Germany.
² Department of Nephrology and Hypertension, Hannover Medical School, Germany.
³ Department of Rheumatology and Immunology, Hannover Medical School, Germany.
⁴ Centre for Individualised Infection Medicine (CiiM), Hannover Medical School, Germany.

PMID: 34753339
DOI: 10.1177/08968608211055631

No abstract available

Publication types

Letter
Comment

MeSH terms

BNT162 Vaccine
COVID-19 Vaccines
COVID-19*
Humans
Immunity, Humoral
Peritoneal Dialysis* / adverse effects
Renal Dialysis / adverse effects
SARS-CoV-2

Substances

COVID-19 Vaccines
BNT162 Vaccine